Radicle Sleep: A Study of Plant Derived Cannabinoids on Sleep and Overall Health Outcomes

NCT ID: NCT05552898

Last Updated: 2023-11-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1750 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-01

Study Completion Date

2022-08-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A randomized, blinded, controlled, direct-to-consumer study assessing the impact of plant derived cannabinoids on sleep and overall health outcomes

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to determine the safety and effects (if any) of different single agent and combination cannabinoid formulations on self-reported sleep and health in adults (21 years of age and older) that reside in the USA. It is a virtual, direct-to-consumer study that will recruit up to 300 participants per study arm (up to 1800 total). Participants will be followed for 5 weeks as they answer electronic surveys about their health, study product usage, and its impact on their health. There are no in-person visits for this study.

After study completion, study investigators will compare the effects of each cannabinoid study product to melatonin isolate. Study investigators will also run post-hoc analyses (correcting for multiple comparisons) to evaluate the significance of health score changes within individual study product arms, and whether there were significant differences in the effect with the addition of components to comparable cannabinoid study products.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will be stratified based on gender and endorsement of problems with energy and/or focus reported during enrollment, then randomized to one of the study arms
Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators
The investigator is blinded to the participants assigned study products. Participants are blinded to the study product they received.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo Control 1

Sleep Product Form 1 - control

Group Type PLACEBO_COMPARATOR

Sleep Study Product Usage

Intervention Type DIETARY_SUPPLEMENT

Participants will use their Radicle Sleep study product as directed for a period of 4 weeks.

Active Product 1.1

Sleep Product Form 1 - active product 1

Group Type EXPERIMENTAL

Sleep Study Product Usage

Intervention Type DIETARY_SUPPLEMENT

Participants will use their Radicle Sleep study product as directed for a period of 4 weeks.

Active Product 1.2

Sleep Product Form 1 - active product 2

Group Type EXPERIMENTAL

Sleep Study Product Usage

Intervention Type DIETARY_SUPPLEMENT

Participants will use their Radicle Sleep study product as directed for a period of 4 weeks.

Active Product 1.3

Sleep Product Form 1 - active product 3

Group Type EXPERIMENTAL

Sleep Study Product Usage

Intervention Type DIETARY_SUPPLEMENT

Participants will use their Radicle Sleep study product as directed for a period of 4 weeks.

Active Product 1.4

Sleep Product Form 1 - active product 4

Group Type EXPERIMENTAL

Sleep Study Product Usage

Intervention Type DIETARY_SUPPLEMENT

Participants will use their Radicle Sleep study product as directed for a period of 4 weeks.

Active Product 1.5

Sleep Product Form 1 - active product 5

Group Type EXPERIMENTAL

Sleep Study Product Usage

Intervention Type DIETARY_SUPPLEMENT

Participants will use their Radicle Sleep study product as directed for a period of 4 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sleep Study Product Usage

Participants will use their Radicle Sleep study product as directed for a period of 4 weeks.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 21 years of age and older
* Resides in the United States
* Endorses symptoms of sleep disturbance
* Selects sleep disturbance as a primary reason for taking a cannabinoid product
* Expresses a willingness to refrain from taking any non-study cannabinoid product (i.e. CBD, CBG, CBC, CBN, THC) for the duration of participant engagement (5 weeks)
* Expresses an interest in taking a study product and not knowing the product identity until the end of the study

Exclusion Criteria

* Pregnant, trying to become pregnant, or breastfeeding
* Reports a diagnosis of liver disease
* Reports being a heavy drinker (defined as drinking 3 or more alcoholic beverages per day)
* Unable to read and understand English
* Lack of reliable daily access to the internet
* Reports taking any medication that warns against grapefruit consumption
Minimum Eligible Age

21 Years

Maximum Eligible Age

105 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Radicle Science

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emily K Pauli, PharmD

Role: PRINCIPAL_INVESTIGATOR

Radicle Science Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Radicle Science, Inc

Del Mar, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://radiclescience.com

Radicle Science, Inc

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RADX-22D01

Identifier Type: -

Identifier Source: org_study_id